Evocutis Plc
("Evocutis" or the "Company")
Result of AGM and General Meeting
At the Annual General Meeting of the Company held earlier today, all resolutions were duly passed.
At the subsequent General Meeting held today, all resolutions were duly passed.
As a consequence of the resolutions being passed at the General Meeting, the Company will, subject to the satisfaction of the remaining conditions of completion of the disposal (as detailed in the circular posted to shareholders on 26 February 2014 and available on the Company's website, www.evocutis.com), dispose of:
· intellectual property rights in SYN1113;
· intellectual property rights in LabSkin™; and
· certain equipment associated with the operation of SYN1113 and/or LabSkin™.
A further announcement will be made in due course.
For further information, please contact:
Evocutis plc |
|
Tom Bannatyne, Chairman |
+44 (0)844 209 8440 |
Dr Gwyn Humphreys, Interim Chief Executive Officer |
Cairn Financial Advisers LLP |
|
James Caithie/Carolyn Sansom |
Tel: +44(0) 20 7148 7900 |
|
www.cairnfin.com |